Volcano Therapeutics Inc has completed the purchase of the global Intravascular Ultrasound (IVUS) and Functional Measurement (FM) Businesses from Jomed Inc and certain other affiliates and subsidiaries of Jomed NV, traded on the Swiss Exchange. The agreement to acquire Jomed was announced earlier this month.

The purchase supports Volcano's strategy to build on Volcano's groundbreaking Virtual Histology IVUS technology which is being developed to enhance conventional IVUS technology. As the integration moves forward, Volcano plans to add its Virtual Histology IVUS technology to the installed base of more than 1,200 Jomed/EndoSonics IVUS consoles currently in clinical use worldwide. Volcano's existing intravascular thermography technology also integrates well with the products from the Jomed/Cardiometrics Functional Measurement business, which includes the pressure and flow wire product lines. Volcano now employs approximately 400 former Jomed employees worldwide, including direct sales organizations in the United States and in most of Europe.

Martin B. Leon, Chairman of the Cardiovascular Research Foundation, Lenox Hill Hospital, New York, New York, stated, "The integration of the Jomed solid-state IVUS technology with the Virtual Histology platform from Volcano presents a new generation of imaging potential in the diagnosis and treatment of coronary artery disease." Dr. Leon continued, "In the era of drug eluting stents, IVUS will play an increasingly important role in lesion assessment and in optimizing stent results."